首页 文献索引 SCI期刊 AI助手
期刊目录筛选

期刊名:Cancer investigation

缩写:CANCER INVEST

ISSN:0735-7907

e-ISSN:1532-4192

IF/分区:2.2/Q3

文章目录 更多期刊信息

共收录本刊相关文章索引1679条
Clinical Trial Case Reports Meta-Analysis RCT Review Systematic Review
Classical Article Case Reports Clinical Study Clinical Trial Clinical Trial Protocol Comment Comparative Study Editorial Guideline Letter Meta-Analysis Multicenter Study Observational Study Randomized Controlled Trial Review Systematic Review
Eliganti Ramalakshmi,Loshma Gunisetti,Sumalatha Lingamgunta Eliganti Ramalakshmi
One of the main reasons for the high death rate in today's world is Breast Cancer (BC), which affects women all over the world. This work proposes a novel Parallel Convolutional-LeNet (PConv-LeNet) technique for BC detection and classificat...
Gianluca Ciarlo,Lena Josfeld,Jutta Hübner Gianluca Ciarlo
Many cancer patients use complementary and alternative medicine (CAM), often seeking a more holistic approach. This study explored whether patients have different communication expectations for oncologists and any professional provider of C...
Omar Abdel-Rahman Omar Abdel-Rahman
Objective: To analyze the patterns of change in diagnostic activity of different cancers before and after 2020, among Canadian jurisdictions covered in the CiNA dataset. ...
Fei Meng,Qingyang Liu,Chenchen Cheng et al. Fei Meng et al.
Purpose: After radical treatment for ovarian cancer, the presence of minimal residual disease (MRD) remains a major obstacle to achieving cure. We explored the prognostic and translational value of MRD assessment by track...
Nazila Farnoush,Amirhossein Rahmani,Mehdi Khosravi-Mashizi et al. Nazila Farnoush et al.
Background: Conflicting results have emerged regarding the relationship between XPD polymorphisms and cutaneous melanoma (CM) susceptibility. This meta-analysis aims to clarify this association. ...
Pooja Bharali,Vikrant Mehta,Subhash Chand et al. Pooja Bharali et al.
HER2-positive breast cancer is an aggressive subtype effectively targeted by monoclonal antibodies such as trastuzumab and pertuzumab, along with ADCs, TKIs, and chemotherapy. Despite clinical success, challenges including therapeutic resis...
Andrezza Moraes Flórido,Catarina Clapis Zordão,Tamires Coelho de Almeida et al. Andrezza Moraes Flórido et al.
Neoadjuvant chemotherapy is used as a treatment for breast cancer patients due to its potential to enable more conservative surgeries. Chemotherapeutic agents can produce side effects that result in functional impairments. The aim of this s...
Fatemeh Vakili,Talat Khadivzadeh,Mohsen Asgharinekah et al. Fatemeh Vakili et al.
Objective: Group counselling (GC) can help people to cope with cancer-induced bodily changes. However, group counselling effects on sexual health of breast cancer patients is largely unknown. The present study aimed at in...
Ja Yoon Heo,Chung Lee,Heesun Shin et al. Ja Yoon Heo et al.
Background: Docetaxel remains a standard treatment for metastatic castration-resistant prostate cancer (mCRPC), yet reliable prognostic markers are lacking. TP53 and RB1, key tumor suppressor genes regulating cell-cycle c...
Elias Abboud,Guy Awad,Marc Boutros et al. Elias Abboud et al.
Osteosarcoma is an aggressive malignancy with a 5-year survival below 30% in metastatic disease, highlighting the need for prognostic tools. A review of 93 studies identified consistent prognostic biomarkers. p53 overexpression was associat...